Tord Inghardt

Human target validation of phosphoinositide 3‐kinase (PI3K)β: effects on platelets and insulin sensitivity, using AZD6482 a novel PI3Kβ inhibitor

Sven Nylander, Bengt Kull, Jan‐Arne Björkman et al. · Journal of Thrombosis and Haemostasis · 2012 · 120 citations · Full text

Molecular Pharmacology, Signal Transduction, Blood Platelet +11

Interfering with the inhibitory mechanism of serpins: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide

Yafeng Xue, Petter Björquist, Tord Inghardt et al. · Structure · 1998 · 92 citations · Full text

Inhibitory Mechanism, Crystal Structure, Protein Assembly +6

Structural and functional characterization of a specific antidote for ticagrelor

Andrew Buchanan, Philip M. Newton, S. KENNETH PEHRSSON et al. · Blood · 2015 · 88 citations · Full text

Identification of the Binding Site for a Low-Molecular-Weight Inhibitor of Plasminogen Activator Inhibitor Type 1 by Site-Directed Mutagenesis

Petter Björquist, J. Ehnebom, Tord Inghardt et al. · Biochemistry · 1998 · 63 citations

Discovery of AZD4831, a Mechanism-Based Irreversible Inhibitor of Myeloperoxidase, As a Potential Treatment for Heart Failure with Preserved Ejection Fraction

Tord Inghardt, Thomas Antonsson, Cecilia Ericsson et al. · Journal of Medicinal Chemistry · 2022 · 35 citations · Full text